Evidence map›Paper›PMID 26265134›Full record

ArticleHistochemistry and cell biology2015

Differential requirements for H/ACA ribonucleoprotein components in cell proliferation and response to DNA damage.

Ping Lin, Maral E Mobasher, Yasaman Hakakian, Veena Kakarla, Anum F Naseem, Heliya Ziai, Faizan Alawi

Open access · greenAbstract read
In one paragraph

Article in Histochemistry and cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ping LinDepartment of Pathology, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Levy Building - Room 328B, Philadelphia, PA, 19104, USA.
Maral E MobasherDepartment of Pathology, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Levy Building - Room 328B, Philadelphia, PA, 19104, USA.
Yasaman HakakianDepartment of Pathology, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Levy Building - Room 328B, Philadelphia, PA, 19104, USA.
Veena KakarlaDepartment of Pathology, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Levy Building - Room 328B, Philadelphia, PA, 19104, USA.
Anum F NaseemDepartment of Pathology, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Levy Building - Room 328B, Philadelphia, PA, 19104, USA.
Heliya ZiaiDepartment of Pathology, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Levy Building - Room 328B, Philadelphia, PA, 19104, USA.
Faizan AlawiDepartment of Pathology, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Levy Building - Room 328B, Philadelphia, PA, 19104, USA. falawi@upenn.edu.
California University of Pennsylvania · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
Understanding molecular mechanisms underlying the formation of the blue nevus andP30AR057217 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI COTSARELIS, GEORGE · 2009 to 2013
$3.2M
Role of dyskerin in oral epithelial homeostasisK08DE021428 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI ALAWI, FAIZAN · 2011 to 2015
$697k
NCI NIH HHS P30 CA016520NCI NIH HHS P30-CA016520NIAMS NIH HHS P30 AR057217NIAMS NIH HHS P30-AR057217NIDCR NIH HHS DE021428NIDCR NIH HHS K08 DE021428
6 · The paper itself

Abstract

H/ACA ribonucleoproteins (RNPs) are comprised of four conserved proteins, dyskerin, NHP2, NOP10, and GAR1, and a function-specifying, noncoding H/ACA RNA. H/ACA RNPs contribute to telomerase assembly and stabilization, and posttranscriptional processing of nascent ribosomal RNA and spliceosomal RNA. However, very little is known about the coordinated action of the four proteins in other biologic processes. As described herein, we observed a differential requirement for the proteins in cell proliferation and identified a possible reliance for these factors in regulation of specific DNA damage biomarkers. In particular, GAR1 expression was upregulated following exposure to all forms of genotoxic stress tested. In contrast, levels of the other proteins were either reduced or unaffected. Only GAR1 showed an altered subcellular localization with a shift from the nucleolus to the nucleoplasm after ultraviolet-C irradiation and doxorubicin treatments. Transient siRNA-mediated depletion of GAR1 and dyskerin arrested cell proliferation, whereas loss of either NHP2 or NOP10 had no effect. Finally, loss of dyskerin, GAR1, NHP2, and NOP10, respectively, limited the accumulation of DNA damage biomarkers. However, the individual responses were dependent upon the specific type of damage incurred. In general, loss of GAR1 had the most suppressive effect on the biomarkers tested. Since the specific responses to genotoxic stress, the contribution of each protein to cell proliferation, and the activation of DNA damage biomarkers were not equivalent, this suggests the possibility that at least some of the proteins, most notably GAR1, may potentially function independently of their respective roles within H/ACA RNP complexes.

Indexed as

DNA DamageApoptosisBiomarkersCell CycleCell ProliferationCells, CulturedFluorescent Antibody Technique, IndirectHumansRibonucleoproteins, Small NucleolarBiomarkersRibonucleoproteins, Small NucleolarCellular stressDyskerinGAR1Genotoxic stresssnoRNA

Identifiers

PMID26265134
PMCPMC5662186
OpenAlexW1185575525

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.